breast cancer

You have access
Copenhagen Rats Display Dominantly Inherited Yet Non-uniform Resistance to Spontaneous, Radiation-induced, and Chemically-induced Mammary Carcinogenesis
MAYUMI NISHIMURA, TATSUHIKO IMAOKA, KAZUHIRO DAINO, YUKIKO NISHIMURA, TOSHIAKI KOKUBO, MASARU TAKABATAKE, SHIZUKO KAKINUMA and YOSHIYA SHIMADA

Anticancer Research May 2022, 42 (5) 2415-2423; DOI: https://doi.org/10.21873/anticanres.15720
Open Access
Dynamic Integrated Backscatter Detects Radiotherapy-induced Cardiac Changes Better than Strain Analysis – A Prospective Three-year Study
SUVI SIRKKU TUOHINEN, TANJA SKYTTA, HEINI HUHTALA, VESA VIRTANEN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and PEKKA RAATIKAINEN

Anticancer Research May 2022, 42 (5) 2507-2517; DOI: https://doi.org/10.21873/anticanres.15729
Open Access
A Higher Mean Heart Radiation Dose Induces Higher Frequency of Multiple Cardiac Changes
SUVI SIRKKU TUOHINEN, HANNA AULA, TANJA SKYTTÄ, HEINI HUHTALA, KONSTA KESKI-PUKKILA, KJELL NIKUS, VESA VIRTANEN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and PEKKA RAATIKAINEN

Anticancer Research May 2022, 42 (5) 2519-2529; DOI: https://doi.org/10.21873/anticanres.15730
Open Access
The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer
MIN HAN, SHIGEO YAMAGUCHI, MAI ONISHI, TOMOAKI FUJII, MASAKI HOSOYA, XUAN WEN, HIDENORI KIDO and SHUNSUKE KATO

Anticancer Research May 2022, 42 (5) 2277-2288; DOI: https://doi.org/10.21873/anticanres.15707
You have access
Combination of DYRK2 and TERT Expression Is a Powerful Predictive Marker for Early-stage Breast Cancer Recurrence
MASUMI TANAKA, SHIN-ICHI YAMASHITA, YASUTERU YOSHINAGA, YASUKO ENOMOTO, YUKI NOHARA, SYUKO ONO, KAZUKI NABESHIMA, AKINORI IWASAKI and TOSHIHIKO SATO

Anticancer Research April 2022, 42 (4) 2079-2085; DOI: https://doi.org/10.21873/anticanres.15689
You have access
A New Method for Obtaining Tumor Interstitial Fluid Applied to Cytokine Analysis of Breast Carcinoma Samples
FELIPE TORRES DANTAS, PEDRO HENRIQUE FELIX-SILVA, HÉLIO HUMBERTO ANGOTTI-CARRARA, FRANCISCO JOSE CANDIDO DOS-REIS, MARIO TABA JUNIOR, SÉRGIO LUÍS SCOMBATTI DE-SOUZA and DANIELA BAZAN PALIOTO

Anticancer Research March 2022, 42 (3) 1327-1332; DOI: https://doi.org/10.21873/anticanres.15600
You have access
Outcome Prediction After Neoadjuvant Chemotherapy (NAC) for Breast Cancer, Using Tumor-infiltrating Lymphocytes Within Fibrotic Foci of Tumor Stroma (FF-TILs)
SHINICHIRO KASHIWAGI, YUKA ASANO, KOJI TAKADA, WATARU GOTO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research March 2022, 42 (3) 1421-1431; DOI: https://doi.org/10.21873/anticanres.15612
Open Access
Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1
AOI OKAMOTO, YOHEI FUNAKOSHI, MASAHIRO OE, RYO TAKAI, HIROTAKA SUTO, YOSHIAKI NAGATANI, MEIKO NISHIMURA, YOSHINORI IMAMURA, TOMONARI KUNIHISA, NAOMI KIYOTA, KOJI MIKI, KOUICHI OHE, HIROKAZU TANINO and HIRONOBU MINAMI

Anticancer Research March 2022, 42 (3) 1199-1205; DOI: https://doi.org/10.21873/anticanres.15586
You have access
The Role of Community Pharmacists in Addressing Medication-related Issues for Breast Cancer Patients Receiving Adjuvant Endocrine Therapy
KINAN MOKBEL and KEFAH MOKBEL

Anticancer Research February 2022, 42 (2) 661-666; DOI: https://doi.org/10.21873/anticanres.15524
You have access
Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort
CARSTEN NIEDER, JOAKIM RESSHEIM, ELLINOR C. HAUKLAND and BÅRD MANNSÅKER

Anticancer Research February 2022, 42 (2) 923-928; DOI: https://doi.org/10.21873/anticanres.15551

Main menu

User menu

Search

breast cancer

Pages